search
Back to results

Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure

Primary Purpose

Atrial Fibrillation, Stroke

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Imaging guidance with TEE and ICE for Left atrial appendage closure
Sponsored by
Kansas City Heart Rhythm Research Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Atrial Fibrillation

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Male/Females Age:18-80 years History of Atrial Fibrillation/Atrial flutter Will have endocardial Left Atrial Appendage Closure (LAAC) with an Amplatzer Amulet or WATCHMAN FLX device Exclusion Criteria: Inability or unwillingness of an individual to give written informed consent Patient not following with our practice after the procedure Complex anatomy for endocardial LAAC Thrombus in LAA Patients with pericardial effusion in pre-op TEE/CCTA Patients currently pregnant (Serum beta HCG completed when labs obtained for the procedure are completed)

Sites / Locations

  • Kansas City Heart Rhythm Institute - Roe ClinicRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Arm 1 - TEE Primary imaging guidance

Arm 2 - ICE Primary Imaging Guidance

Arm Description

TEE is the primary imaging guidance with 4D ICE is the secondary

4D ICE is the primary imaging guidance and TEE is the secondary

Outcomes

Primary Outcome Measures

Success of Implantation of Left Atrial Appendage Closure (LAAC) device
Success of Implantation of Amulet or Watchman FLX device

Secondary Outcome Measures

Intraprocedural measurements
Transeptal access view, LAA thrombus, Stability of the device, Peri-device leaks, Device Repositioning, Clarity of mitral valve or pulmonary vein impingement will be noted as Yes/No from Echocardiogram
Intraprocedural measurements
LAA size in different sites will be noted from Echocardiograms
Intraprocedural measurements - LAA device size
LAA device size will be measured based on the LAA size
Location of the leaks
Location of the leaks will be identified
Intraprocedural measurements
Procedural duration, Fluoroscopic time

Full Information

First Posted
September 11, 2023
Last Updated
September 25, 2023
Sponsor
Kansas City Heart Rhythm Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT06061757
Brief Title
Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
Official Title
Use of 4D Intracardiac Echocardiography (4D-ICE) in Conjunction With Transesophageal Echocardiography (TEE) for Left Atrial Appendage Closure (LAAC)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 10, 2023 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kansas City Heart Rhythm Research Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural guidance similar to Transesophageal echocardiography (TEE) (GE 6VT-D ULTRASOUND TRANSDUCER) for Left atrial appendage closure (LAAC). The study will enroll approximately 52 subjects and will be followed through 12 months.
Detailed Description
Standard intraprocedural guidance for transcatheter left atrial appendage closure (LAAC) employs a multi-modality integrated approach combining fluoroscopy for guiding the delivery system, and transesophageal echocardiography (TEE) for intracardiac characterization to guide device selection and monitor procedural complications. Successful implantation of the device is confirmed with contrast-enhanced fluoroscopy and color doppler flow imaging on TEE. TEE is the current gold standard for procedural guidance but requires general anesthesia (GA) to avoid patient motion and discomfort during the procedure. General anesthesia, however, is associated with pulmonary complications and patient discomfort due to endotracheal intubation. Intraprocedural LAAC guidance under local anesthesia or conscious sedation might help mitigate these GA-related disadvantages and has motivated multiple clinical studies, establishing intracardiac echocardiography (ICE) as a safe and feasible alternative to TEE. The new generation of NuVision ICE catheter offers a larger imaging volume of 90° x 90° with multiplanar reformatted (MPR) echo views for better visualization of anatomical landmarks and procedural guidance and aid in sizing of the device. This has a potential to improve outcomes and reduce procedure times while lowering healthcare costs. In this study, Role of NuVision Intracardiac Echocardiographic (ICE) catheter with Tranesopheal echocardiography (TEE) in predicting intra-procedural outcomes and success of implantation in patients undergoing left atrial appendage occlusion will be assessed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Stroke

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
52 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm 1 - TEE Primary imaging guidance
Arm Type
Experimental
Arm Description
TEE is the primary imaging guidance with 4D ICE is the secondary
Arm Title
Arm 2 - ICE Primary Imaging Guidance
Arm Type
Experimental
Arm Description
4D ICE is the primary imaging guidance and TEE is the secondary
Intervention Type
Device
Intervention Name(s)
Imaging guidance with TEE and ICE for Left atrial appendage closure
Intervention Description
The occluder size for both LAAC devices will be selected based on the maximal diameter of the LAA orifice following the manufacturer guidelines and using the maximal length of the LAA measured on Echocardiogram. Intraprocedural measurements of the LAA width and depth were acquired on both ICE and TEE per protocol. Both ICE and TEE will be used to assess for any procedural complications prior to insertion of the device delivery sheath.
Primary Outcome Measure Information:
Title
Success of Implantation of Left Atrial Appendage Closure (LAAC) device
Description
Success of Implantation of Amulet or Watchman FLX device
Time Frame
1 Day
Secondary Outcome Measure Information:
Title
Intraprocedural measurements
Description
Transeptal access view, LAA thrombus, Stability of the device, Peri-device leaks, Device Repositioning, Clarity of mitral valve or pulmonary vein impingement will be noted as Yes/No from Echocardiogram
Time Frame
1 Day
Title
Intraprocedural measurements
Description
LAA size in different sites will be noted from Echocardiograms
Time Frame
1 Day
Title
Intraprocedural measurements - LAA device size
Description
LAA device size will be measured based on the LAA size
Time Frame
1 Day
Title
Location of the leaks
Description
Location of the leaks will be identified
Time Frame
1 Day
Title
Intraprocedural measurements
Description
Procedural duration, Fluoroscopic time
Time Frame
1 Day
Other Pre-specified Outcome Measures:
Title
Post Procedural Outcomes
Description
Presence of any Peri-device leaks (PDL), Device Related Thrombus (DRTs), Micro migration and device tilt will be noted.
Time Frame
45 Days, 6 Months and 12 Months
Title
Post Procedural Outcomes - Size of the leaks
Description
Leaks if any, leaks size will be measured
Time Frame
45 Days, 6 Months and 12 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male/Females Age:18-80 years History of Atrial Fibrillation/Atrial flutter Will have endocardial Left Atrial Appendage Closure (LAAC) with an Amplatzer Amulet or WATCHMAN FLX device Exclusion Criteria: Inability or unwillingness of an individual to give written informed consent Patient not following with our practice after the procedure Complex anatomy for endocardial LAAC Thrombus in LAA Patients with pericardial effusion in pre-op TEE/CCTA Patients currently pregnant (Serum beta HCG completed when labs obtained for the procedure are completed)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Donita Atkins
Phone
816-651-1969
Email
datkins@kchrf.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dhanunjaya Lakkireddy, MD
Organizational Affiliation
Kansas City Heart Rhythm Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kansas City Heart Rhythm Institute - Roe Clinic
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
First Name & Middle Initial & Last Name & Degree
Dhanunjaya Lakkireddy, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
11997272
Citation
Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002 Apr 23;105(16):1887-9. doi: 10.1161/01.cir.0000015698.54752.6d.
Results Reference
background
PubMed Identifier
28866032
Citation
Saw J. Intracardiac Echocardiography for Endovascular Left Atrial Appendage Closure: Is it Ready for Primetime? JACC Cardiovasc Interv. 2017 Nov 13;10(21):2207-2210. doi: 10.1016/j.jcin.2017.07.002. Epub 2017 Aug 30. No abstract available.
Results Reference
background
PubMed Identifier
32435343
Citation
Khalili H, Patton M, Taii HA, Bansal P, Brady M, Taylor J, Gurung A, Maini B. 4D Volume Intracardiac Echocardiography for Intraprocedural Guidance of Transcatheter Left Atrial Appendage Closure. J Atr Fibrillation. 2019 Dec 31;12(4):2200. doi: 10.4022/jafib.2200. eCollection 2019 Dec.
Results Reference
background
PubMed Identifier
34157847
Citation
Ranard LS, Khalique OK, Donald E, Agarwal V, Hamid N, Hahn RT, Ng V, Brady M, Gurung A, Ali ZA, Leon MB, Sommer R, Vahl TP. Transcatheter Left Atrial Appendage Closure Using Preprocedural Computed Tomography and Intraprocedural 4-Dimensional Intracardiac Echocardiography. Circ Cardiovasc Interv. 2021 Jul;14(7):e010686. doi: 10.1161/CIRCINTERVENTIONS.121.010686. Epub 2021 Jun 23. No abstract available.
Results Reference
background
Citation
http://cardiacvascularnews.com/nuvera-announces-successful-first-in-human-use-of-nuvision-ice-catheter/
Results Reference
background

Learn more about this trial

Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure

We'll reach out to this number within 24 hrs